EQL Pharma AB
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2018-11-29 | EQL Pharma AB | Katarina Wallentin | Senior Regulatory Affairs Manager | Acquisition | 806 | 12 | SEK | 9 672 | 2018-11-28 |
| 2018-11-28 | EQL Pharma AB | Alexander Brising | Business Development Director | Acquisition | 2 100 | 12,25 | SEK | 25 725 | 2018-11-26 |
| 2018-11-28 | EQL Pharma AB | Alexander Brising | Business Development Director | Acquisition | 1 437 | 12,1 | SEK | 17 387,7 | 2018-11-26 |
| 2018-11-28 | EQL Pharma AB | Alexander Brising | Business Development Director | Acquisition | 1 500 | 12,25 | SEK | 18 375 | 2018-11-25 |
| 2018-11-28 | EQL Pharma AB | Alexander Brising | Business Development Director | Acquisition | 1 803 | 12,45 | SEK | 22 447,35 | 2018-11-26 |
| 2018-11-28 | EQL Pharma AB | Alexander Brising | Business Development Director | Acquisition | 1 803 | 12,45 | SEK | 22 447,35 | 2018-11-26 |
| 2018-11-28 | EQL Pharma AB | Alexander Brising | Business Development Director | Acquisition | 1 803 | 12,45 | SEK | 22 447,35 | 2018-11-26 |
| 2018-11-21 | EQL Pharma AB | christer fåhraeus | VD | Acquisition | 26 543 | 6 | SEK | 159 258 | 2018-11-20 |
| 2018-11-20 | EQL Pharma AB | Axel Schörling | Operativ chef, COO | Subscription | 219 | 6 | SEK | 1 314 | 2018-11-15 |
| 2018-11-19 | EQL Pharma AB | Alexander Brising | Business Development Director | Subscription | 106 | 6 | SEK | 636 | 2018-11-15 |
| 2018-11-18 | EQL Pharma AB | Alexander Brising | Business Development Director | Exercise decrease | 9 000 | 0 | SEK | 0 | 2018-11-12 |
| 2018-11-18 | EQL Pharma AB | Alexander Brising | Business Development Director | Subscription | 1 500 | 6 | SEK | 9 000 | 2018-11-12 |
| 2018-11-18 | EQL Pharma AB | Alexander Brising | Business Development Director | Subscription | 25 | 6 | SEK | 150 | 2018-11-15 |
| 2018-11-16 | EQL Pharma AB | Björn Allan Beermann | Styrelseledamot/suppleant | Acquisition | 270 | 13,15 | SEK | 3 550,5 | 2018-11-15 |
| 2018-11-16 | EQL Pharma AB | Björn Allan Beermann | Ekonomi/finanschef | Acquisition | 3 645 | 10,22 | SEK | 37 251,9 | 2018-10-21 |
| 2018-11-16 | EQL Pharma AB | Björn Allan Beermann | Ekonomi/finanschef | Exercise decrease | 12 145 | 0 | SEK | 0 | 2018-11-13 |
| 2018-11-16 | EQL Pharma AB | Björn Allan Beermann | Ekonomi/finanschef | Subscription | 2 024 | 6 | SEK | 12 144 | 2018-11-13 |
| 2018-11-16 | EQL Pharma AB | Björn Allan Beermann | Ekonomi/finanschef | Acquisition | 1 355 | 10,23 | SEK | 13 861,65 | 2018-10-22 |
| 2018-11-16 | EQL Pharma AB | Christer Fåhraeus | VD | Exercise decrease | 10 300 | 0 | SEK | 0 | 2018-11-12 |
| 2018-11-16 | EQL Pharma AB | Alexander Brising | Business Development Director | Exercise decrease | 2 300 | 0 | SEK | 0 | 2018-11-12 |